| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $167.3M | -5.7% |
| Cost of Revenue | $100.8M | +1.5% |
| Gross Profit | $66.4M | -14.8% |
| R&D Expense | $61.4M | -3.1% |
| SG&A Expense | $40.1M | -2.0% |
| Operating Income | -$68.0M | -11.0% |
| Pre-tax Income | -$85.6M | -20.2% |
| Income Tax | -$197K | +71.4% |
| Net Income | -$85.4M | -21.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.3M | -88.5% |
| Accounts Receivable | $46.6M | -19.7% |
| Inventory | $18.6M | +7.8% |
| Current Assets | $89.7M | -42.9% |
| Total Assets | $125.1M | -36.0% |
| Current Liabilities | $198.7M | +169.9% |
| Total Liabilities | $205.9M | -2.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$47.2M | +29.3% |
| Capital Expenditures | $3.1M | -48.7% |
| Investing Cash Flow | -$3.1M | +48.7% |
| Financing Cash Flow | -$5.6M | -104.8% |
| Free Cash Flow | -$50.3M | +30.9% |
| Stockholders' Equity |
| -$80.8M |
| -397.2% |